M65 TFA | MedChemExpress (MCE)
M65 TFA is a deleted peptide of maxadilan (61 a.a.) with deletion of the residues between positions 24 and 42 and is a specific antagonist of PACAP type 1 receptor that inhibits ANP secretion and can be used for relevant researches[1][2].
| Trivial name | M65 TFA |
| Catalog Number | HY-P4127A |
| Research Area | Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer |
| Purity | ≥98.0% |
| SMILES | O=C([C@@H](N)CSSC[C@H](NC1=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]3CCC(O)=O)=O)CCCCN)=O)CC4=CC=CC=C4)=O)C(C)C)=O)CO)=O)CC(N)=O)=O)=O)CCC2)=O)C(C)C)=O)CC(N)=O)=O)CO)=O)CC5=CNC=N5)=O)CC6=CNC=N6)=O)C)=O)CCC(N)=O)=O)CCCCN)=O)CCC(N)=O)=O)CSSC[C@H](NC3=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)CCCCN)=O)CC7=CC=CC=C7)=O)CCC(O)=O)=O)CCCCN)=O)CCCCN)=O)CCCCN)=O)CCC(N)=O)=O)CCCCN)=O)CCSC)=O)=O)CC(O)=O)=O)CC(O)=O)=O)[C@H](CC)C)=O)C)=O)CCCCN)=O)CCCNC(N)=N)=O)CC8=CC=CC=C8)=O)CCC(N)=O)=O)N[C@H](C(N[C@H](C(N[C@H]1[C@@H](C)O)=O)C)=O)CC(O)=O.OC(C(F)(F)F)=O.[x] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/m65-tfa.html |